Cotización Galmed Pharmaceuticals - GLMD

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Último Precio

3.02

Postura de Compra

3.02

Postura de Venta

3.08

Volume Operado de la Acción

63,044

2.86 Rango del Día 3.18

2.73 Rango de 52 semanas 23.80

Capitalización de Mercado [m]

1.944M

Precio Anterior

2.88

Precio de Apertura

2.99

Hora

3.02

Última hora de negociación

15:19:59

Volumen financiero

US$ 186,957

Precio Promedio Ponderado

2.9655

Volumen promedio (3 m)

3,212,477

Acciones en circulación

643,690

Rendimiento del Dividendo

Ratio Precio/Utilidad

-0.29

Beneficio por acción (BPA)

-10.74

turnover

Beneficio neto

-6.91M

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aram... Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis. Mostrar más

Sector

Pharmaceutical Preparations

Industria

Pharmaceutical Preparations

Sitio web

www.galmedpharma.com

Sede

Tel Aviv, Center, Isr

Fundado

Galmed Pharmaceuticals Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GLMD. The last closing price for Galmed Pharmaceuticals was US$2.88. Over the last year, Galmed Pharmaceuticals shares have traded in a share price range of US$ 2.73 to US$ 23.80.

Galmed Pharmaceuticals currently has 643,690 shares in issue. The market capitalisation of Galmed Pharmaceuticals is US$1.85 million. Galmed Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.29.

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-0.22	-6.79012345679	3.24	3.451	2.7301	85928	3.02904094	CS
4	-0.66	-17.9347826087	3.68	4.81	2.7301	133049	3.76488112	CS
12	-0.58	-16.1111111111	3.6	23.8	2.73	3212477	11.318485	CS
26	-1.54	-33.7719298246	4.56	23.8	2.73	1530136	11.19452903	CS
52	-1.66	-35.4700854701	4.68	23.8	2.73	870067	10.42806357	CS
156	-524.38	-99.427379598	527.4	559.8	2.73	381959	34.65036356	CS
260	-806.98	-99.6271604938	810	1328.4	2.73	299943	196.50271057	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
MVSTMicrovast Holdings Inc	US$ 0.29 (60.49%)	4.31M
ONMDOneMedNet Corporation	US$ 1.2101 (27.38%)	5.08M
MULNMullen Automotive Inc	US$ 3.70 (24.16%)	6.95M
RKLBRocket Lab USA Inc	US$ 18.09 (23.40%)	6.28M
CYCCCyclacel Pharmaceuticals Inc	US$ 0.50 (21.95%)	2.55M
SYRSSyros Pharmaceuticals Inc	US$ 0.3068 (-88.76%)	7.25M
VINOGaucho Group Holdings Inc	US$ 1.97 (-55.73%)	133.79k
VRMVroom Inc	US$ 5.59 (-36.98%)	36.66k
NANano Labs Ltd	US$ 5.65 (-26.62%)	321.92k
PIIIP3 Partners Inc	US$ 0.29 (-25.72%)	86.94k
JGLOJP Morgan Global Select Equity ETF	US$ 63.13 (0.00%)	18.88M
SOUNSoundHound AI Inc	US$ 7.44 (-1.59%)	10.36M
LGMKLogicMark Inc	US$ 0.1705 (-4.48%)	8.47M
SYRSSyros Pharmaceuticals Inc	US$ 0.3068 (-88.76%)	7.25M
MULNMullen Automotive Inc	US$ 3.70 (24.16%)	6.95M